z-logo
Premium
Efficacy and tolerance of immune checkpoint inhibitors for non‐small cell lung cancer patients with interstitial lung disease – Reply
Author(s) -
Kobayashi Haruki
Publication year - 2020
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13785
Subject(s) - medicine , lung cancer , interstitial lung disease , disease , lung , lung disease , oncology
See Letter

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom